Literature DB >> 19822702

Bacteriophage cocktail for the prevention of biofilm formation by Pseudomonas aeruginosa on catheters in an in vitro model system.

Weiling Fu1, Terri Forster, Oren Mayer, John J Curtin, Susan M Lehman, Rodney M Donlan.   

Abstract

Microorganisms develop biofilms on indwelling medical devices and are associated with device-related infections, resulting in substantial morbidity and mortality. This study investigated the effect of pretreating hydrogel-coated catheters with Pseudomonas aeruginosa bacteriophages on biofilm formation by P. aeruginosa in an in vitro model. Hydrogel-coated catheters were exposed to a 10 log(10) PFU ml(-1) lysate of P. aeruginosa phage M4 for 2 h at 37 degrees C prior to bacterial inoculation. The mean viable biofilm count on untreated catheters was 6.87 log(10) CFU cm(-2) after 24 h. The pretreatment of catheters with phage reduced this value to 4.03 log(10) CFU cm(-2) (P < 0.001). Phage treatment immediately following bacterial inoculation also reduced biofilm viable counts (4.37 log(10) CFU cm(-2) reduction; P < 0.001). The regrowth of biofilms on phage-treated catheters occurred between 24 and 48 h, but supplemental treatment with phage at 24 h significantly reduced biofilm regrowth (P < 0.001). Biofilm isolates resistant to phage M4 were recovered from catheters pretreated with phage. The phage susceptibility profiles of these isolates were used to guide the development of a five-phage cocktail from a larger library of P. aeruginosa phages. The pretreatment of catheters with this cocktail reduced the 48-h mean biofilm cell density by 99.9% (from 7.13 to 4.13 log(10) CFU cm(-2); P < 0.001), but fewer biofilm isolates were resistant to these phages. These results suggest the potential of applying phages, especially phage cocktails, to the surfaces of indwelling medical devices for mitigating biofilm formation by clinically relevant bacteria.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19822702      PMCID: PMC2798481          DOI: 10.1128/AAC.00669-09

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  34 in total

Review 1.  Bacteriophage therapy of bacterial infections: an update of our institute's experience.

Authors:  B Weber-Dabrowska; M Mulczyk; A Górski
Journal:  Arch Immunol Ther Exp (Warsz)       Date:  2000       Impact factor: 4.291

2.  Initiation of biofilm formation by Pseudomonas aeruginosa 57RP correlates with emergence of hyperpiliated and highly adherent phenotypic variants deficient in swimming, swarming, and twitching motilities.

Authors:  E Déziel; Y Comeau; R Villemur
Journal:  J Bacteriol       Date:  2001-02       Impact factor: 3.490

Review 3.  Epidemiological typing of Pseudomonas aeruginosa.

Authors:  T L Pitt
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1988-04       Impact factor: 3.267

4.  Effects of hydrogel/silver coatings on in vitro adhesion to catheters of bacteria associated with urinary tract infections.

Authors:  D G Ahearn; D T Grace; M J Jennings; R N Borazjani; K J Boles; L J Rose; R B Simmons; E N Ahanotu
Journal:  Curr Microbiol       Date:  2000-08       Impact factor: 2.188

5.  Adherence of coagulase-negative staphylococci to plastic tissue culture plates: a quantitative model for the adherence of staphylococci to medical devices.

Authors:  G D Christensen; W A Simpson; J J Younger; L M Baddour; F F Barrett; D M Melton; E H Beachey
Journal:  J Clin Microbiol       Date:  1985-12       Impact factor: 5.948

6.  Morphology of Pseudomonas aeruginosa typing phages of the Lindberg set.

Authors:  H W Ackermann; C Cartier; S Slopek; J F Vieu
Journal:  Ann Inst Pasteur Virol       Date:  1988 Oct-Dec

7.  Reduction in exopolysaccharide viscosity as an aid to bacteriophage penetration through Pseudomonas aeruginosa biofilms.

Authors:  G W Hanlon; S P Denyer; C J Olliff; L J Ibrahim
Journal:  Appl Environ Microbiol       Date:  2001-06       Impact factor: 4.792

8.  Bacteriophage T4 multiplication in a glucose-limited Escherichia coli biofilm.

Authors:  B D Corbin; R J McLean; G M Aron
Journal:  Can J Microbiol       Date:  2001-07       Impact factor: 2.419

Review 9.  Biofilms: survival mechanisms of clinically relevant microorganisms.

Authors:  Rodney M Donlan; J William Costerton
Journal:  Clin Microbiol Rev       Date:  2002-04       Impact factor: 26.132

10.  Cell death in Pseudomonas aeruginosa biofilm development.

Authors:  Jeremy S Webb; Lyndal S Thompson; Sally James; Tim Charlton; Tim Tolker-Nielsen; Birgit Koch; Michael Givskov; Staffan Kjelleberg
Journal:  J Bacteriol       Date:  2003-08       Impact factor: 3.490

View more
  111 in total

1.  Assessment of sterility in fluid bags maintained for chronic use.

Authors:  Kristin A Matthews; Douglas K Taylor
Journal:  J Am Assoc Lab Anim Sci       Date:  2011-09       Impact factor: 1.232

2.  The use of drip flow and rotating disk reactors for Staphylococcus aureus biofilm analysis.

Authors:  Kelly Schwartz; Rachel Stephenson; Margarita Hernandez; Nicolays Jambang; Blaise R Boles
Journal:  J Vis Exp       Date:  2010-12-27       Impact factor: 1.355

3.  Phage therapy to control multidrug-resistant Pseudomonas aeruginosa skin infections: in vitro and ex vivo experiments.

Authors:  A Vieira; Y J Silva; A Cunha; N C M Gomes; H-W Ackermann; A Almeida
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2012-07-10       Impact factor: 3.267

Review 4.  Novel approaches to the diagnosis, prevention, and treatment of medical device-associated infections.

Authors:  Paschalis Vergidis; Robin Patel
Journal:  Infect Dis Clin North Am       Date:  2012-03       Impact factor: 5.982

Review 5.  Applying insights from biofilm biology to drug development - can a new approach be developed?

Authors:  Thomas Bjarnsholt; Oana Ciofu; Søren Molin; Michael Givskov; Niels Høiby
Journal:  Nat Rev Drug Discov       Date:  2013-10       Impact factor: 84.694

6.  When the resistance gets clingy: Pseudomonas aeruginosa harboring metallo-β-lactamase gene shows high ability to produce biofilm.

Authors:  L R R Perez; A L S Antunes; A L P Freitas; A L Barth
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2011-08-04       Impact factor: 3.267

Review 7.  Enhancing the utility of existing antibiotics by targeting bacterial behaviour?

Authors:  Geraint B Rogers; Mary P Carroll; Kenneth D Bruce
Journal:  Br J Pharmacol       Date:  2012-02       Impact factor: 8.739

8.  Vibriophages Differentially Influence Biofilm Formation by Vibrio anguillarum Strains.

Authors:  Demeng Tan; Amalie Dahl; Mathias Middelboe
Journal:  Appl Environ Microbiol       Date:  2015-04-24       Impact factor: 4.792

9.  Bacteriophage-mediated control of a two-species biofilm formed by microorganisms causing catheter-associated urinary tract infections in an in vitro urinary catheter model.

Authors:  Susan M Lehman; Rodney M Donlan
Journal:  Antimicrob Agents Chemother       Date:  2014-12-08       Impact factor: 5.191

10.  Antipseudomonal Bacteriophage Reduces Infective Burden and Inflammatory Response in Murine Lung.

Authors:  Rishi Pabary; Charanjit Singh; Sandra Morales; Andrew Bush; Khalid Alshafi; Diana Bilton; Eric W F W Alton; Anthony Smithyman; Jane C Davies
Journal:  Antimicrob Agents Chemother       Date:  2015-11-16       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.